Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · AdaptHealth (AHCO)

AdaptHealth posts Q4 net loss of $102.8 million on $128.0 million goodwill charge

Negative Impact 4 of 5 earnings Written later

AdaptHealth reported fourth-quarter 2025 net revenue of $846.3 million, down 1.2%, and a net loss attributable to the company of $102.8 million, compared with net income of $50.3 million a year earlier. The loss includes a non-cash goodwill impairment charge of $128.0 million, and Adjusted EBITDA fell 18.7% to $163.1 million. The company also issued 2026 guidance of $3.44 billion to $3.51 billion in net revenue and $680 million to $730 million in Adjusted EBITDA.

Key points

  • Q4 2025 net revenue was $846.3 million, down from $856.6 million; Adjusted EBITDA was $163.1 million, down from $200.6 million.
  • Q4 2025 net loss attributable to AdaptHealth was $102.8 million, including a $128.0 million non-cash goodwill impairment tied to the Diabetes Health unit.
  • Full-year 2025 net loss attributable to AdaptHealth was $70.8 million, versus net income of $90.4 million in 2024.
  • 2026 guidance: net revenue of $3.44 billion to $3.51 billion, Adjusted EBITDA of $680 million to $730 million, and free cash flow of $175 million to $225 million.

The filing

CompanyAdaptHealth (AHCO)
Form8-K, current report
Filed with the SECFeb 24, 2026, 7:11 AM ET
Accession number0001628280-26-010872

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 24, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.